NEW YORK, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ultra Clean Holdings, Inc. ("Ultra Clean" or "the Company") (NASDAQ:UCTT). Investors who purchased Ultra Clean securities prior to May 6, 2024, and continue to hold to the present, are encouraged […]

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ:QNTM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS" or "the Company") (NYSE:PACS). Investors who purchased PACS securities prior to April 11, 2024, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CTO Realty Growth, Inc. ("CTO" or "the Company") (NYSE:CTO). Investors who purchased CTO securities prior to February 18, 2021, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Klarna Group PLC ("Klarna" or the "Company") (NYSE:KLAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Coupang, Inc. ("Coupang" or the "Company") (NYSE:CPNG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Trip.com Group Limited ("Trip.com" or "the Company") (NASDAQ:TCOM). Investors who purchased Trip.com securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TCOM.

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Synopsys, Inc. ("Synopsys" or "the Company") (NASDAQ:SNPS). Investors who purchased Synopsys securities prior to December 4, 2024, and continue to hold to the present, are encouraged to obtain additional

(NasdaqGM:GAUZ), NEW YORK, Jan. 18, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025 and November 13, 2025, both dates inclusive (the “Class Period”), of the important February 6, 2026 lead plaintiff deadline. SO WHAT: If you